Recombinase-based genetic circuits in human T cells for cellular immunotherapy
Treatments using a patient’s own T cells to target cancer have applied advances in genetic engineering and cancer immunotherapy as the basis for a powerful, targeted cell-based therapy. Tumor-infiltrating lymphocytes and T cells that have been genetically modified to express cancer antigen-specific...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/30728 |